Patents by Inventor Joshua Robert Schultz

Joshua Robert Schultz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140005096
    Abstract: Disclosed herein, in certain embodiments, are peptides for use in inhibiting the interactions of PF4 and RANTES. Further disclosed herein, are methods for treating an inflammatory disease, disorder, condition, or symptom. In some embodiments, the method comprises co-administering an agent that inhibits the interactions of PF4 and RANTES and a second active agent.
    Type: Application
    Filed: July 15, 2013
    Publication date: January 2, 2014
    Applicant: Carolus Therapeutics, Inc.
    Inventors: Joshua Robert SCHULTZ, Benedikt VOLLRATH, Court TURNER
  • Publication number: 20110262386
    Abstract: Disclosed herein, in certain embodiments, is a method for treating an MIF-mediated disorder. In some embodiments, the method comprises administering an active agent that inhibits (i) MIF binding to CXCR2 and CXCR4 and/or (ii) MIF-activation of CXCR2 and CXCR4; (iii) the ability of MIF to form a homomultimer; or a combination thereof.
    Type: Application
    Filed: March 20, 2009
    Publication date: October 27, 2011
    Applicant: CAROLUS THERPEUTICS, INC.
    Inventors: Jürgen Bernhagen, Joshua Robert Schultz, Benedikt Vollrath, Alma Zernecke, Christian Weber
  • Publication number: 20110256130
    Abstract: Disclosed herein, in certain embodiments, are methods and compositions for treating inflammatory disorders. In some embodiments, the methods comprise co-administering synergistic combinations of modulators of inflammation.
    Type: Application
    Filed: December 1, 2009
    Publication date: October 20, 2011
    Inventors: Joshua Robert Schultz, Benedikt Vollrath, Court Turner
  • Publication number: 20110044988
    Abstract: Disclosed herein, in certain embodiments, is a method for treating an inflammatory disorder. In some embodiments, the method comprises administering an active agent that inhibits (i) MIF binding to CXCR2 and CXCR4 and/or (ii) MIF-activation of CXCR2 and CXCR4; (iii) the ability of MIF to form a homomultimer; or a combination thereof.
    Type: Application
    Filed: March 20, 2009
    Publication date: February 24, 2011
    Applicant: CAROLUS THERPEUTICS, INC.
    Inventors: Jürgen Bernhagen, Joshua Robert Schultz, Benedikt Vollrath, Alma Zernecke, Christian Weber
  • Publication number: 20100183598
    Abstract: Disclosed herein, in certain embodiments, is a method for treating a cardiovascular disorder. In some embodiments, the method comprises co-administering an inhibitor of inflammation and an agent used to treat a cardiovascular disorder.
    Type: Application
    Filed: November 12, 2009
    Publication date: July 22, 2010
    Applicant: CAROLUS THERAPEUTICS, INC.
    Inventors: Joshua Robert Schultz, Benedikt Vollrath, Court Turner
  • Publication number: 20100093636
    Abstract: Disclosed herein, in certain embodiments, are peptides for use in inhibiting the interactions of PF4 and RANTES. Further disclosed herein, are methods for treating an inflammatory disease, disorder, condition, or symptom. In some embodiments, the method comprises co-administering an agent that inhibits the interactions of PF4 and RANTES and a second active agent.
    Type: Application
    Filed: October 6, 2009
    Publication date: April 15, 2010
    Applicant: CAROLUS THERAPEUTICS, INC.
    Inventors: Joshua Robert Schultz, Benedikt Vollrath, Court Turner